Myriad Genetics Inc (MYGN)
Payables turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue (ttm) | US$ in thousands | 252,200 | 254,100 | 248,200 | 241,600 | 236,200 | 228,500 | 221,300 | 213,200 | 202,000 | 193,900 | 191,300 | 195,300 | 197,600 | 198,900 | 195,300 | 178,300 | 178,100 | 180,600 | 186,100 | 200,000 |
| Payables | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Payables turnover | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
December 31, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $252,200K ÷ $—K
= —
The payables turnover ratio for Myriad Genetics Inc indicates how efficiently the company is managing its accounts payable. The formula for payables turnover is calculated as Cost of Goods Sold divided by Average Accounts Payable.
However, based on the provided data, the payables turnover ratio for Myriad Genetics Inc is not available for the periods from March 31, 2020 to December 31, 2024, as the values are marked as "—". This lack of data prevents us from analyzing the company's performance in terms of how quickly it pays its suppliers.
It is important for investors and stakeholders to monitor the payables turnover ratio over time as it can provide insights into the company's liquidity, cash flow management, and relationships with suppliers. A high payables turnover ratio may indicate that the company is efficiently managing its payables and has good relationships with suppliers. Conversely, a low payables turnover ratio may suggest inefficiencies or potential cash flow issues.
Without specific data points for the payables turnover ratio, further analysis regarding Myriad Genetics Inc's performance in managing its accounts payable cannot be performed at this time.
Peer comparison
Dec 31, 2024